Guardant Health, Inc. (GH) Analyst Forecast

$46.18

south_east
-$1.42 (-2.98%)
Day's range
$46.02
Day's range
$48.08

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
08/21/2024 UBS Dan Leonard $40.00 $27.68   44.51%
08/08/2024 Craig-Hallum Bill Bonello $37.00 $31.37   17.97%
08/08/2024 Jefferies Tycho Peterson $40.00 $33.96   17.79%
07/29/2024 BTIG Mark Massaro $50.00 $35.28   41.72%
06/28/2024 Guggenheim Subbu Nambi $36.00 $28.88   24.65%
06/04/2024 Canaccord Genuity Kyle Mikson $38.00 $27.41   38.64%
06/02/2024 Jefferies Tycho Peterson $32.00 $27.10   18.08%
05/23/2024 BTIG Mark Massaro $45.00 $22.51   99.91%
05/22/2024 Canaccord Genuity Kyle Mikson $30.00 $23.01   30.38%
04/24/2024 Craig-Hallum Chase Knickerbocker $28.00 $17.94   56.12%
09/27/2023 Piper Sandler David Westenberg $40.00 $27.59   44.98%
12/16/2022 Morgan Stanley Tejas Savant $80.00 $41.26   93.89%
12/16/2022 Canaccord Genuity Kyle Mikson $65.00 $41.26   57.54%
10/05/2022 Stephens Mason Carrico $99.00 $59.78   65.61%
05/08/2022 J.P. Morgan Julia Qin $125.00 $39.32   217.9%
06/02/2021 Goldman Sachs Matthew Sykes $160.00 $117.90   35.71%

Guardant Health, Inc. FAQ's

Guardant Health, Inc. has been rated by research analysts at UBS, Craig-Hallum, Jefferies, BTIG, Guggenheim, Canaccord Genuity in the past 90 days.